Skip to content

Dr. Van der Cruyssen Stef

Active Private limited companyfounded 2020active for 6 yearsBroekstraat 76A, 9220 Hamme (Vl.)KBO/BCE: BE 0752.880.841

Lifetime

5 annual accounts with figures on one time axis
peak of €195,832 in 2024
€141,034▼ 28.0%
peak of €181,516 in 2021
€85,379▼ 28.8%
peak of €310,979 in 2022
€96,530▲ 766%
€35,248▼ 73.3%
Board1 name since 2020
1 director
Documentsfilings and deeds
15-09-202646 days late
2025micro format
Gross margin from €195,832 to €141,034Result from €119,951 to €85,379Equity from €11,151 to €96,530Debts from €132,057 to €35,248Cash from €56,915 to €77,348

Key points

from the 2025 annual accounts

Equity

€96,530 ▲ 766%
€11,2002024€96,5002025

Equity rose in 2025 from €11,151 to €96,530.

Liquidity

2.95 was 0.82 in 2024

Short-term debts fell from €131,375 to €34,531.

Filings

5 annual accounts 5 late
AprilJune31 JulyOctober20222024

The 2024 accounts came in latest, 67 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as Dr. Van der Cruyssen Stef has now. Each dot stands for 68 companies, two years later.

94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for Dr. Van der Cruyssen Stef. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 26-08-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0752880841
Incorporation Founding capital of €6,200, 62 shares · Founded by · appointed as director · published on 26-08-2020 · Gazette deed
First establishment Loystraat 106, Hamme (Vl.)
All 12 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Van der Cruyssen Stef Hamme (Vl.) €131,778 €141,034 73.3% -
DR. KAREL BUYSE ,HUISARTS Beveren-Kruibeke-Zwijndrecht €129,078 €145,778 2.3% -
DR. VERCRUYSSE L. – DR. DE BROUWER M. Ghent €122,512 €138,942 1.6% -
DRTSTULENS Bilzen-Hoeselt €124,933 €150,552 86.8% -
Dr. Vanstraelen Frederik Genk €147,107 €140,758 46.3% -
Dokter Stéphanie De Rechter Herent €126,450 €152,591 0.1% -
Dr. Marieke Lemiengre Kortrijk €120,416 €143,729 4.2% -

These companies have the same main activity as Dr. Van der Cruyssen Stef: general medical practice (NACE 86210). They are comparable in size and age: total assets between €120,000 and €147,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 24-08-2020Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.306.884.7819220 Hamme (Vl.), since 24-08-2020
Financial year end
31 December
Peppol
Reachable since 10-02-2026
Company details

Annual accounts 2025

≈ €250,000estimated
€131,778▼ 8.0%
Filing
Filed on 15-09-2026
Financials

Insights on Dr. Van der Cruyssen Stef

Dr. Van der Cruyssen Stef files the micro format. That format states no turnover. The gross margin fell from €182,164 in 2021 to €141,034 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Van der Cruyssen Stef

What is the company number of Dr. Van der Cruyssen Stef?
The company number of Dr. Van der Cruyssen Stef is 0752.880.841. The VAT number is the same number with BE in front: BE 0752.880.841.
Where is Dr. Van der Cruyssen Stef based?
The registered office is at Broekstraat 76A, 9220 Hamme (Vl.).Company details
What does Dr. Van der Cruyssen Stef do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Van der Cruyssen Stef?
Dr. Van der Cruyssen Stef is a private limited company (BV).
When was Dr. Van der Cruyssen Stef founded?
Dr. Van der Cruyssen Stef was founded on 24-08-2020.
Is Dr. Van der Cruyssen Stef still active?
Yes, Dr. Van der Cruyssen Stef is an active enterprise in the KBO register.
What is the turnover of Dr. Van der Cruyssen Stef?
The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €141,034 and 30 comparable companies (NACE 86210). It probably lies between €200,000 and €320,000.Financials
Is Dr. Van der Cruyssen Stef profitable?
In financial year 2025, Dr. Van der Cruyssen Stef made a profit of €85,379.
Where can I find the annual accounts of Dr. Van der Cruyssen Stef?
Dr. Van der Cruyssen Stef filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Van der Cruyssen Stef due?
Dr. Van der Cruyssen Stef must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.